@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:10376
  skos:prefLabel "antihistaminas"@es, "antihistamines"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:related nalt:307569 .

<https://lod.nal.usda.gov/naltv#Chemical>
  rdfs:label "Chemical"@en ;
  a owl:Class .

nalt:286
  skos:prefLabel "medicamentos"@es, "drugs"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:narrower nalt:307569 .

nalt:6555
  skos:prefLabel "hipersensibilidad"@es, "hypersensitivity"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:related nalt:307569 .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:307569
  skos:altLabel "anti-allergic drugs"@en, "antiallergics"@en ;
  a skos:Concept, <https://lod.nal.usda.gov/naltv#Chemical> ;
  skos:broader nalt:286 ;
  skos:hiddenLabel "antiallergic drugs"@en, "anti-allergic agent"@en, "antiallergic drug"@en, "anti-allergic"@en, "antiallergic agent"@en, "antiallergic"@en, "antiallergic agents"@en, "anti-allergic drug"@en ;
  skos:prefLabel "anti-allergic agents"@en, "agentes antialérgicos"@es ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:definition nalt:307569_def ;
  ns0:marc001 "79941" ;
  skos:related nalt:10376, nalt:6555 ;
  dc:created "2017-09-01"^^xsd:date ;
  dc:modified "2020-04-13"^^xsd:date .

nalt:307569_def
  rdf:value "Agentes utilizados para tratar reacciones alérgicas. La mayoría de estos fármacos evita la liberación de mediadores inflamatorios o inhibe las acciones de los mediadores liberados en sus células diana."@es, "Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells."@en ;
  dc:source "Medical Subject Headings 2017" ;
  a ns0:Definition .